135 related articles for article (PubMed ID: 38590038)
1. Predictors of disease course in systemic juvenile idiopathic arthritis.
Kaplan MM; Tekin ZE; Çelikel E; Güngörer V; Karagöl C; Öner N; Polat MC; Öztürk D; Özçelik E; Ekici MI; Acar BÇ
Mod Rheumatol; 2024 Apr; ():. PubMed ID: 38590038
[TBL] [Abstract][Full Text] [Related]
2. Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?
Batu ED; Sener S; Balık Z; Bayındır Y; Cam V; Kasap Cuceoglu M; Uysal O; Aliyev E; Basaran Ö; Bilginer Y; Özen S
Clin Rheumatol; 2024 Jan; 43(1):415-421. PubMed ID: 38012469
[TBL] [Abstract][Full Text] [Related]
3. The frequency of macrophage activation syndrome and disease course in systemic juvenile idiopathic arthritis.
Çakan M; Karadağ ŞG; Tanatar A; Ayaz NA
Mod Rheumatol; 2020 Sep; 30(5):900-904. PubMed ID: 31462146
[No Abstract] [Full Text] [Related]
4. Systemic onset juvenile idiopathic arthritis: a single center experience.
Sağ E; Uzunoğlu B; Bal F; Sönmez HE; Demir S; Bilginer Y; Özen S
Turk J Pediatr; 2019; 61(6):852-858. PubMed ID: 32134578
[TBL] [Abstract][Full Text] [Related]
5. Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study.
Lukjanoviča K; Šlēziņa I; Dāvidsone Z; Šantere R; Budarina K; Staņēviča V
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109756
[No Abstract] [Full Text] [Related]
6. Systemic juvenile idiopathic arthritis-associated lung disease: A retrospective cohort study.
Belozerov KE; Solomatina NM; Isupova EA; Kuznetsova AA; Kostik MM
World J Clin Pediatr; 2024 Mar; 13(1):88912. PubMed ID: 38596441
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease.
Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS
Front Immunol; 2018; 9():2995. PubMed ID: 30619348
[No Abstract] [Full Text] [Related]
9. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
[TBL] [Abstract][Full Text] [Related]
10. Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study.
Otar Yener G; Paç Kısaarslan A; Ulu K; Atalay E; Haşlak F; Özdel S; Bozkaya Yücel B; Gezgin Yıldırım D; Çakmak F; Öztürk K; Çakan M; Balık Z; Hasbal Akkuş C; Yıldız M; Erat T; Çetin BŞ; Yılmaz M; Bağlan E; Laçinel Gürlevik S; Atasayan V; Karadağ ŞG; Adrovic A; Çağlayan Ş; Tanatar A; Demirkan FG; Coşkuner T; Akgün Ö; Kasap Cüceoğlu M; Kavrul Kayaalp G; Şahin S; Başaran Ö; Demir F; Barut K; Çiftel M; Gürses D; Baykan A; Özsürekçi Y; Karagöz T; Sönmez HE; Bilginer Y; Aktay Ayaz N; Aydoğ Ö; Yüksel S; Sözeri B; Kasapçopur Ö; Özen S
Rheumatol Int; 2022 May; 42(5):879-889. PubMed ID: 34491393
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hip disease in the systemic arthritis subtype of juvenile idiopathic arthritis.
Batthish M; Feldman BM; Babyn PS; Tyrrell PN; Schneider R
J Rheumatol; 2011 May; 38(5):954-8. PubMed ID: 21285170
[TBL] [Abstract][Full Text] [Related]
12. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW
Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047
[TBL] [Abstract][Full Text] [Related]
13. Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
Barut K; Adrovic A; Sahin S; Tarcin G; Tahaoglu G; Koker O; Yildiz M; Kasapcopur O
Int J Rheum Dis; 2019 Sep; 22(9):1661-1669. PubMed ID: 31273940
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
15. Course, Outcome and Complications in Children with Systemic Onset Juvenile Idiopathic Arthritis.
Dewoolkar M; Cimaz R; Chickermane PR; Khubchandani RP
Indian J Pediatr; 2017 Apr; 84(4):294-298. PubMed ID: 28229369
[TBL] [Abstract][Full Text] [Related]
16. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
17. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors.
Schulert GS; Yasin S; Carey B; Chalk C; Do T; Schapiro AH; Husami A; Watts A; Brunner HI; Huggins J; Mellins ED; Morgan EM; Ting T; Trapnell BC; Wikenheiser-Brokamp KA; Towe C; Grom AA
Arthritis Rheumatol; 2019 Nov; 71(11):1943-1954. PubMed ID: 31379071
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis.
Maller J; Fox E; Park KT; Paul SS; Baszis K; Borocco C; Prahalad S; Quartier P; Reinhardt A; Schonenberg-Meinema D; Shipman-Duensing L; Terreri MT; Simard J; Lavi I; Chalom E; Hsu J; Zisman D; Mellins ED;
J Rheumatol; 2021 Apr; 48(4):567-574. PubMed ID: 32541073
[TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
[TBL] [Abstract][Full Text] [Related]
20. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis.
Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
